Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just 6 trading days before $26M trial resumes!
Monday, August 4th
Tuesday, August 5th
Wednesday, August 6th
Thursday, August 7th
Friday, August 8th
Monday, August 11th
Tuesday, August 12th <--- TRIAL RESUMES!
08/12/2014 at 09:30 am in department 48 at 111 North Hill Street, Los Angeles, CA 90012
Jury Trial(18-DAY ESTIMATE(10TH CONT.))
Reference: http://www.lasuperiorcourt.org/civilcasesummarynet/ui/index.aspx?
Case Number:
BC427192
Who likes 1150% profit?
After today, there are 9 more trading days before the PPJ Enterprise v. Grewal trial resumes. Here is a list of the sought restitution for damages committed upon PPJ Enterprises by Grewal:
1) Plaintiff seeks damages for the First Claim for Relief in the amount of $2,800,000 plus legal interest since the money was taken.
2) Plaintiff seeks damages for the Second Claim for Relief in the amount of $476,000 plus interest as allowed by law for the fraudulent actions of the Defendants.
3) Plaintiff seeks damages for the Third Claim for Relief in the amount of $65,774.15 plus interest as allowed by law for the fraudulent actions of the Defendants.
4) Plaintiff seeks damages for the Fourth Claim for Relief in the amount of $10,000,000 plus interest as allowed by law.
5) Plaintiff seeks 50% ownership of the Surgery Center assets and its revenue in the amount of $10,000,000.
6) Plaintiff seeks for the Fifth Claim for Relief for recovery of the sum of $2,875,754,16 paid by mistake to Defendants.
7) Plaintiff seeks recovery of attorney’s fees and costs.
8) Plaintiff seeks a preliminary and permanent injunction for the actions of Defendants.
9) Plaintiff seeks punitive damages in a sum according to proof at time of trial.
10) Plaintiff seeks an accounting of funds received by Defendants.
11) Plaintiff seeks that the court establish a constructive trust upon the assets and accounts of Defendants.
12) Plaintiff seeks any other and further relief that the court considers proper.
To add up the damages:
$ 2,800,000.00
$ 476,000.00
$ 65,774,15
$10,000,000.00
$10,000,000.00
$ 2,875,754.15
==============
$26,217,528.30 <-- TOTAL
It is now 45 minutes from market close today, and as of right now, PPJ Enterprise is worth $2,498,109.06:
(2,498,109,058 shares outstanding x $0.0010/share)
Adding $26,217,528.30 to the value of PPJ would bring its total value to $28,715,637.36.
That would make the PPS of PPJE stock rise to $0.0115/share.
Who likes 1150% profit?
The 1/29/2014 PR states that the blood testing lab “...will perform Blood Culture Identification (BCID) Panel tests for a comprehensive list of 24 pathogens and 3 antibiotic resistance genes associated with bloodstream infections.”
This does not mean that this laboratory would have a generic testing capability to test for any DNA sequences. Odds are extremely high that there is no capability to test beyond the 24 pathogens and 3 genes described in the PR.
I think that you are figuring that the type of blood testing that would be performed to determine the existence of those pathogens and genes would mean that the lab is performing some type of DNA sequencing. In reality, there are very specific test reagents that engage in a detectable chemical reaction in the presence of the targeted chemical substance... and in this regard, pathogens and genes are chemical substances.
If the targeted substance exists in the test sample, you get a reaction.
If the targeted substance does not exist in the test sample, you do not get a reaction.
In most cases, the degree of completed reaction indicates the concentration of the targeted chemical substance in the test sample.
To test for ANYTHING else beyond what is already possible, the manufacturer of the diagnostic analyzer would have to invent a new test kit, with a new test reagent, for each of the additional chemical substances which one wished to target as substances to find in a test sample. It is not that this is not possible. It is just that it is not trivial to add additional tests. If the manufacturer knows how to construct a viable test reagent, it can take months of testing to validate the new reagent as reliable enough to sell. If the manufacturer does not know how to construct a viable test reagent, it can take years of research to figure it out.
This type of testing is completely different than generic genome sequencing where you can put the DNA from any living thing, or well-preserved formerly living thing, into the sequencer, and it determines the complete genetic make up of the DNA in the sample. This form of testing still costs hundreds of dollars per test sample, and it is almost certainly NOT the type of testing that PPJ could do with their blood testing lab.
I especially like the part of the fifth paragraph of the 6/19 PR that talks about Hemp, Inc.’s subsidiary, IHMMCC, providing PPJ with consulting advice about sales, marketing and communications:
Just 10 trading days before $26M trial resumes!
PPJ ENTERPRISE INC VS NARINDER S GREWAL ET AL RESUMES 08/12/2014
08/12/2014 at 09:30 am in department 48 at 111 North Hill Street, Los Angeles, CA 90012
Jury Trial(18-DAY ESTIMATE(10TH CONT.))
Reference: http://www.lasuperiorcourt.org/civilcasesummarynet/ui/index.aspx?
Case Number:
BC427192
This ticker seems to be an exercise in bizarre.
1) No one has posted anything here in 2 years.
2) ALK has a record 2Q results, so it drops nearly $3/share.
Very, very bizarre.
So $UPERMAN PM'ed me to suggest that I would have problems filing my fantasy PR with FINRA.
When I did a search on the FINRA newsroom web page, I did not find where PPJ filed their PR with FINRA either:
http://search.finra.org/search?q=ppj&x=9&y=8&filter=0&entqr=0&ie=UTF-8&ud=1&oe=UTF-8&site=fnrw_newsreleases&client=fnrw_global&output=xml_no_dtd&proxystylesheet=fnrw_newsreleases
Of course, it is possible that PPJ may have filed today's PR with FINA somewhere else. In any case, I serioously doubt that FINRA would have the ability to verify today's PR story any more than the rest of us.
I did find today's PR by looking in various other places:
http://www.otcmarkets.com/stock/PPJE/news (which indicated that COMTEX was also carrying the PR)
http://www.eteligis.com/ViewSubmission.aspx?submissionRequest=27083
http://www.accesswire.com/418209/PPJ-Enterprise-Awarded-Contract-With-Mississippi-Pain-Management-Firm
$26M trial for PPJE resumes in 15 tradedays
It is really ridiculous how small PPJE volume is (38K now), and it is even more ridiculous how small overall OTC volume is (6 billion yesterday).